ICAAC 46th

Drupal spam blocked by CleanTalk.
Title Content type
BAL4815, a New Antifungal Agent: Determination of Quality Control Limits for Susceptibility Testing by Methods of the European Committee on Antimicrobial Susceptibility Testing (EUCAST). (click for details)
3M-003, An Agonist Of Toll-like Receptors (TLRs) 7 And 8, Significantly Upregulates Effector Cell Anti-fungal Activity. (click for details)
Prospective, Multicenter Study of Caspofungin (CAS) for Prophylaxis in High Risk Liver Transplantation (LT). (click for details)
Molecular Characterization of Cyp51A and B Genes From Voriconazole-Resistant and -Susceptible Isolates of Aspergillus Flavus. (click for details)
In Vitro Activity of Posaconazole Compared with Seven Antifungal Agents against 80 Clinical and 15 Environmental Isolates of Exophiala Dermatitidis. (click for details)
Activity In Vitro of 27 Combinations of Licensed Antifungal Agents against Scedosporium apiospermum (Sa) and Scedosporium prolificans (Sp). (click for details)
Impact of a Caspofungin (CAS) Restriction Policy on Appropriateness of Use and the Financial Implications in a Large Tertiary Hospital. (click for details)
Body Mass Index (BMI) Significantly Increased with Macrolide Treatment in Patients with Chronic Necrotizing Pulmonary Aspergillosis. (click for details)
Micafungin (MCF) Alone or in Combination with Other Licensed Antifungal Therapy (OLAT) in Bone Marrow Transplant (BMT) Recipients with Invasive Aspergillosis (IA). (click for details)
Cross Reactivity in the Platelia Aspergillus Galactomannan Antigenemia Assay Caused by Histoplasmosis. (click for details)

Pages

Subscribe to ICAAC 46th